SCIEX Reviews

Propel is a modern, AI-powered product management platform built for today’s manufacturers. It brings Product Lifecycle Management (PLM), Quality Management System (QMS), Product Information Management (PIM), and robust supplier management together in one cloud-based solution, giving teams a single, always-accurate view of their products across the entire lifecycle. With AI embedded directly into the platform through Propel One, teams can automate routine tasks, surface insights faster, and make more confident decisions using real product and quality data. AI helps reduce manual effort, identify risks earlier, and keep work moving across change management, quality events, and product operations. Propel replaces spreadsheets and disconnected systems with a governed digital product record that spans engineering, quality, operations, supply chain, and product teams. Built-in workflows standardize change control, streamline quality processes, and support compliance without slowing teams down. Every update and approval is tracked with full traceability, helping manufacturers reduce errors, shorten cycle times, and improve cross-functional collaboration. Trusted by medical device, high tech, and industrial manufacturers, Propel is designed for complex products and regulated environments. The platform scales easily as products, teams, and requirements grow, providing a strong foundation for long-term innovation. Propel delivers enterprise-grade security and reliability through its architecture on the Salesforce platform, including robust data protection and access controls. Customers do not need to be Salesforce users to benefit from Propel’s security and capabilities. Propel has been recognized by Deloitte as a fast-growing technology company and named to the Inc. 5000 list of fastest-growing private companies, reflecting strong customer adoption and momentum helping manufacturers modernize how they build, manage, and deliver products.

AlisQI is a Quality Management platform built for process and batch manufacturers who want operational control without adding administrative overhead. Where many QMS platforms were designed around document storage and event tracking, AlisQI was architected as a data-first system. Quality, laboratory, and production data are structured and connected in a single operational backbone. This enables teams to see deviations earlier, understand performance trends in context, and act before issues escalate into waste, rework, or customer complaints. The platform includes modular capabilities across document control, training, deviations, CAPA, audits, risk management, supplier quality, SPC, and EHS. These capabilities are deployed through focused, ready-to-use Solvers that combine workflows, logic, dashboards, and analytics to address specific operational challenges without unnecessary scope. Because the system is built on structured, connected data, manufacturers can apply practical AI directly inside their workflows. This includes automated extraction of supplier COA data without predefined templates, conversational access to quality records, intelligent rule generation, and pattern recognition across incidents to strengthen corrective action effectiveness. Solvers are production-ready from the outset and evolve as products, processes, or sites change. Improvements do not require custom development or large IT programs, allowing organizations to modernize quality step by step. Manufacturers across chemicals, plastics, packaging, food and beverage, automotive, and industrial sectors use AlisQI to reduce firefighting, increase predictability, strengthen compliance, and turn quality data into operational intelligence.

InSilicoTrials.com is a digital platform designed to provide a straightforward interface for computational modeling and simulation, equipped with a variety of integrated, user-friendly in silico tools. This platform primarily caters to experts in the medical device and pharmaceutical sectors. The tools tailored for medical devices enable computational evaluations across numerous biomedical fields, such as radiology, orthopedics, and cardiovascular health, during critical phases like product design, development, and validation. For those in the pharmaceutical domain, the site offers in silico tools that assist in every stage of drug discovery and development across various therapeutic fields. Our innovative cloud-based platform is built on the principles of crowdscience, enabling users to effectively leverage validated models to decrease their research and development costs. Moreover, users can access an ever-growing library of models available on a pay-per-use basis, which guarantees both flexibility and accessibility to meet their research requirements. This blend of advanced technology and user-centric design makes InSilicoTrials.com a valuable resource for professionals striving to enhance their research and development processes.